Hedge Fund - Alpine Associates

Robert Emil Zoellner, Jr. Bio, Returns, AUM, Net Worth

Alpine Associates Management Inc., oversees the Alpine funds established in 1976, renowned for delivering exceptional absolute returns. Engaging in merger arbitrage and equity trading since their inception, the Alpine funds boast an outstanding 46-year track record of absolute returns, showcasing historical non-correlation to the S&P 500. Demonstrating a consistent history of remarkable returns across various market cycles, the Firm that is led by Robert Zoellner, Jr. currently manages a total of $1.85 billion in assets.

Having joined Alpine in 1983, Robert Zoellner, Jr. currently holds the positions of Chief Executive Officer and Chief Investment Officer. With a specialization in merger arbitrage and equity trading, he also serves as a director and is a member of the risk management committee. Bringing extensive experience to his role, he has been a portfolio manager since 1993 and previously served as a trader at Alpine. Mr. Zoellner initiated his career as a specialist clerk with Lasker, Stone, and Stern in 1983. He holds a B.A. in Economics from the University of Colorado.

Meanwhile, in its primary strategy, Alpine employs merger arbitrage, concentrating on transactions featuring definitive merger contracts. The firm holds the belief that merger arbitrage is an exceptionally resilient strategy, demonstrating consistent profitability, low volatility, and advantageous performance in rising interest rate environments. Given that the typical M&A transaction concludes within a few months, an arbitrage portfolio undergoes continuous self-liquidation. Consequently, arbitrage swiftly adapts to shifts in the investment climate.

Robert Emil Zoellner, Jr.
Fund Profile
Filing Period:
Fund Name: Alpine Associates
Manager Robert Emil Zoellner, Jr.
Portfolio Value $1,950,127,757
Change This QTR +1.02%
Fund Holdings Sector Distribution
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1. HES 1,644,700 $237,099,952 NEW 12.15%
2. SPLK 1,284,050 $195,625,030 +1129% 10.03%
3. CPRI 2,447,800 $122,977,472 +1% 6.3%
4. AMED 1,271,097 $120,830,481 +23% 6.19%
5. MRTX 1,881,400 $110,532,250 NEW 5.66%
News, Interviews and Investor Letters